Fluorescence polarization assays
Fluorescence polarization measurements were performed in 384-well microplates (black polystyrene, non-treated, Corning). The fluorescence polarization was recorded using a TRIAD multimode microplate reader (from Dynex), with excitation and emission wavelengths of 485 and 535 nm, respectively. The fluorescent probe (a fluorescein labelled heparin-like hexasaccharide previously prepared in our lab 1 ) was dissolved in PBS buffer (10 mM, pH 7.4).
The protein (recombinant human midkine, FGF-2 or pleiotrophin, from Peprotech) was dissolved in PBS buffer (10 mM, pH 7.4) containing 1% BSA. Synthetic oligosaccharides 2, 3 and 7 were dissolved in PBS buffer (10 mM, pH 7.4). Compounds 1, 4-6 were dissolved in PBS buffer at 1 mM concentration in the presence of 10% (v/v) DMSO. For the screening assay at a fixed concentration (25 µM) of inhibitor, 10 µL of a 40 nM probe solution and 20 µL of a 325 nM pleiotrophin solution were mixed with 10 µL of a 100 µM S3 inhibitor solution. The total sample volume in each well was 40 µL and the final buffer composition was PBS + 0.5% BSA. The final concentrations of inhibitor, fluorescent probe and protein in each well were 25 µM, 10 nM and 163 nM, respectively. After stirring for 5 min in the dark, fluorescence polarization was recorded. Two control samples were included in the experiment. The first one only contained fluorescent probe and afforded the expected value for 100% inhibition; the second one contained pleiotrophin and probe, in the absence of inhibitor, and gave the polarization value corresponding to 0% inhibition. Blank wells contained 20 µL of pleiotrophin solution (325 nM) and 20 µL of PBS buffer and their measurements were subtracted from all values. All samples were performed in replicates of three.
Competition assay using heparin-functionalized microtiter plates 1) Preparation of heparin-coated microplate wells: A heparin hexasaccharide containing an amine functionalized linker, previously synthesized in our group, 2 was dissolved in sodium bicarbonate buffer (50 mM, pH 9.6) containing hexadecyltrimethylammonium bromide (1 mM) to afford 10 µM sugar solutions. These solutions were transferred to the wells of Nunc Immobilizer Amino TM 384 microtiter plates (from Thermo Scientific) (20 µL/well). Blank wells were incubated with 100 mM ethanolamine in sodium bicarbonate buffer (50 mM, pH 9.6) (80 µL/well). The plate was shaken overnight at room temperature and the wells were emptied and washed with water. All wells were then blocked by 1 h incubation with 100 mM ethanolamine in sodium bicarbonate buffer, washed with water and stored at 4ºC until use. 
4-Methoxyphenyl 2-O-benzoyl-3-O-benzyl-4,6-di-O-levulinoyl-β-D-glucopyranoside (9):
Lev 2 O preparation: LevOH (1.8 mL, 18.2 mmol) was added at 0ºC to a solution of 1,3-dicyclohexylcarbodiimide (1.88 g, 9.1 mmol) in CH 2 Cl 2 (25 mL). After stirring 5 min at room temperature, the mixture was cooled and filtered, and the urea precipitate was washed with additional CH 2 Cl 2 (7 mL), to give 32 mL of a 0. Methoxyphenyl 3-O-(2-O-benzoyl-3-O-benzyl-4,6-di-O-levulinoyl-β-D-glucopyranosyl) Hz, H-1'), 4.56 (2d, 2H, CH 2 (Bn)), 4.36 (dd, 1H, J 5, 6a = 1.8 Hz, J 6a, 6b = 12. 1 Hz, 4.27 (dd, 1H, J 2, 3 = 10.9 Hz, J 3, 4 = 2.8 Hz, 4.20 (d, 1H, 2H, 3H, 4H, Me (OMP) ), 3.63 (t, 1H, H-5) , 2.84-S11 2.35 (m, 8H, CH 2 (Lev)), 2.20-2.15 (2s, 6H, CH 3 (Lev)); 13 C-NMR (100 MHz, CDCl 3 /CD 3 OD 5:1): δ 208.9, 207.2, 172.7, 171.8, 165.7 (5 x CO) , 157.9 (q, J C,F = 36.7 Hz, COCF 3 ), 155.4-114.1 (Ar), 101.1 (C-1'), 99.8 (C-1), 79.9 (C-3'), 77.6 (C-3), 74.8, 74.6 (CH 2 (Bn), C-5), 73.3 (C-2'), 72.0 (C-5'), 70.2 (C-4'), 67.8 (C-4), 62.2 (C-6'), 61.3 (C-6), 55.5 (Me (OMP)), 52.9 (C-2), 37.9, 37.7 (CH 2 (Lev)), 29.6, 29.4 (CH 3 (Lev) Hz, H-1), 4.69 (2d, 2H, CH 2 (Bn)), 4.62 (d, 1H, J 3,4 
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